Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Prolactin response to buspirone was reduced in violent compared to nonviolent parolees.

Cherek DR, Moeller FG, Khan-Dawood F, Swann A, Lane SD.

Psychopharmacology (Berl). 1999 Feb;142(2):144-8.

PMID:
10102766
2.

Quantifying the 5-HT1A agonist action of buspirone in man.

Bridge MW, Marvin G, Thompson CE, Sharma A, Jones DA, Kendall MJ.

Psychopharmacology (Berl). 2001 Nov;158(3):224-9.

PMID:
11713611
3.
5.
6.

Increased prolactin response to buspirone in chronic fatigue syndrome.

Sharpe M, Clements A, Hawton K, Young AH, Sargent P, Cowen PJ.

J Affect Disord. 1996 Nov 4;41(1):71-6.

PMID:
8938208
7.

Ipsapirone neuroendocrine challenge: relationship to aggression as measured in the human laboratory.

Moeller FG, Allen T, Cherek DR, Dougherty DM, Lane S, Swann AC.

Psychiatry Res. 1998 Oct 19;81(1):31-8.

PMID:
9829648
8.

Prolactin response to buspirone challenge in the presence of dopaminergic blockade.

Maskall DD, Zis AP, Lam RW, Clark CM, Kuan AJ.

Biol Psychiatry. 1995 Aug 15;38(4):235-9.

PMID:
8547445
9.

Impact of cortisol on buspirone stimulated prolactin release: a double-blind placebo-controlled study.

Dinan TG, Scott LV, Thakore J, Naesdal J, Keeling PW.

Psychoneuroendocrinology. 2001 Oct;26(7):751-6.

PMID:
11500255
10.
11.

5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.

de Boer SF, Koolhaas JM.

Eur J Pharmacol. 2005 Dec 5;526(1-3):125-39. Review.

PMID:
16310183
12.

Studies of violent and nonviolent male parolees: I. Laboratory and psychometric measurements of aggression.

Cherek DR, Moeller FG, Schnapp W, Dougherty DM.

Biol Psychiatry. 1997 Mar 1;41(5):514-22.

PMID:
9046983
13.

A double-blind placebo-controlled study of buspirone-stimulated prolactin release in non-ulcer dyspepsia--are central serotoninergic responses enhanced?

Dinan TG, Mahmud N, Rathore O, Thakore J, Scott LV, Carr E, Naesdal J, O'Morain CA, Keeling PW.

Aliment Pharmacol Ther. 2001 Oct;15(10):1613-8.

14.

Studies of violent and nonviolent male parolees: II. Laboratory and psychometric measurements of impulsivity.

Cherek DR, Moeller FG, Dougherty DM, Rhoades H.

Biol Psychiatry. 1997 Mar 1;41(5):523-9.

PMID:
9046984
15.

The effect of chronic fluvoxamine on hormonal and psychological responses to buspirone in normal volunteers.

Anderson IM, Deakin JF, Miller HE.

Psychopharmacology (Berl). 1996 Nov;128(1):74-82.

PMID:
8944409
16.

Differing central amine receptor sensitivity in different migraine subtypes? A neuroendocrine study using buspirone.

Cassidy EM, Tomkins E, Sharifi N, Dinan T, Hardiman O, O'Keane V.

Pain. 2003 Feb;101(3):283-90.

PMID:
12583871
17.

[Effect of buspirone on aggressive and anxiety behavior of male mice with various aggressive experience].

Bondar' NP, Kudriavtseva NN.

Eksp Klin Farmakol. 2003 Jul-Aug;66(4):12-6. Russian.

PMID:
14558344
18.

The effects of buspirone on perceived exertion and time to fatigue in man.

Marvin G, Sharma A, Aston W, Field C, Kendall MJ, Jones DA.

Exp Physiol. 1997 Nov;82(6):1057-60.

19.

EEG effects of buspirone and pindolol: a method of examining 5-HT1A receptor function in humans.

McAllister-Williams RH, Massey AE.

Psychopharmacology (Berl). 2003 Mar;166(3):284-93.

PMID:
12589521
20.

Serotonin supersensitivity: the pathophysiologic basis of non-ulcer dyspepsia? A preliminary report of buspirone/prolactin responses.

Dinan TG, Yatham LN, Barry S, Chua A, Keeling PW.

Scand J Gastroenterol. 1990 May;25(5):541-4.

PMID:
2359983

Supplemental Content

Support Center